Agency opinion regarding the next steps for the REVELA 13 monitoring program following the opinion of the Expert Committee on Occupational Health and the Environment

In 2018, the PACA Regional Health Agency (ARS PACA) consulted Santé publique France on the advisability of extending the work of the Observatory for Kidney, Bladder, and Acute Leukemia Cancers in Adults in the Bouches-du-Rhône department to other types of cancer (REVELA 13) (referral 18-A-00255 / DSPE-0718-4564-D dated July 13, 2018).

N.B.: Parts 1, 2, and 3 of the Opinion reproduce the analysis and conclusions formulated by the Health, Environment, and Work Expert Committee (CE SET). Part 4 contains the opinion formulated by Santé publique France, based on the CE’s recommendations.

See also:

In relation to

Our latest news

Appel à candidatures d'experts pour le remplacement d’un membre « sage-femme » du Comité national d'experts sur la mortalité maternelle (CNEMM)

news

Call for Nominations to Fill Vacancies on the National Reference Centers...

news

Public Health France Conference: November 9, 2026

news

Shamonda Virus: First Human Case Detected in France—What Do We Know?